2023
DOI: 10.7759/cureus.37472
|View full text |Cite
|
Sign up to set email alerts
|

Comparative Study Between the First and Second Wave of COVID-19 Deaths in India: A Single Center Study

Abstract: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continuously evolving, and many mutant variants of the virus are circulating in the world. Recurrent waves of COVID-19 have caused enormous mortality all across the globe. Considering the novelty of the virus, it becomes crucial for healthcare experts and policymakers to understand the demographic and clinical attributes of inpatient deaths in the first and second waves of COVID-19. MethodsThis hospital record-based comparative study was condu… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 22 publications
1
0
0
Order By: Relevance
“…Besides the high viral load in the second wave, we did not observe substantial hospitalization. Similar findings were observed in a comparative study from a tertiary care hospital in India, determining high mortality due to tachypnoea, hypoxia, and lack of an aggressive management system (ICU) could be the possible reason for the reduction in hospitalization percentage (Tendulkar et al, 2023).…”
Section: Discussionsupporting
confidence: 84%
“…Besides the high viral load in the second wave, we did not observe substantial hospitalization. Similar findings were observed in a comparative study from a tertiary care hospital in India, determining high mortality due to tachypnoea, hypoxia, and lack of an aggressive management system (ICU) could be the possible reason for the reduction in hospitalization percentage (Tendulkar et al, 2023).…”
Section: Discussionsupporting
confidence: 84%
“…Monoclonal antibody therapies also became a focal point, offering passive immunity to highrisk individuals. Vaccination campaigns began during this phase, marking a critical milestone in the pandemic response [49].…”
Section: A Comprehensive Review Of Treatment Approaches During the 1 ...mentioning
confidence: 99%